Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,569.30
-6.70 (-0.43%)
At close: Aug 21, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 164.38 billion as of August 21, 2026. Its market cap has decreased by -7.21% in one year.
Market Cap
164.38B
Enterprise Value
160.07B
Revenue
11.08B
Ranking
n/a
PE Ratio
59.69
Stock Price
1,569.30
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 164.38B, an increase of 66.66%. That is a compound annual growth rate of 18.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 164.38B | 16.77% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |
| Caplin Point Laboratories | 195.43B |
| AstraZeneca Pharma India | 187.71B |
| Jubilant Pharmova | 137.58B |
| CORONA Remedies | 129.75B |
| Viyash Scientific | 118.70B |